Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Trial details
- Registry ID
- NCT07863193
- Drugs studied
- Denifanstat
TrialRedline tracks 3 clinical trials sponsored by Sagimet Biosciences Inc.: 1 Phase 3, 2 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)NCT07863193 | Denifanstat | Recruiting | 2027-08Estimated |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)NCT04906421 | TVB-2640 | Completed | 2023-10-02Actual |
| Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)NCT03938246 | TVB-2640 25 mg (US), TVB-2640 50 mg (China), TVB-2640 50 mg (US), TVB-2640 75 mg (US) | Completed | 2021-10-02Actual |
Names as written in the registry records.